Bleeding risk of rivaroxaban and edoxaban with and without amiodarone in atrial fibrillation patients: a prospective cohort study.
Saved in:
| Title: | Bleeding risk of rivaroxaban and edoxaban with and without amiodarone in atrial fibrillation patients: a prospective cohort study. |
|---|---|
| Authors: | Wang Z; Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China., Yang F; Department of Pharmacy, Shanghai Geriatric Medical Center, Shanghai, China., Wang Q; Department of Pharmacy, Shanghai Geriatric Medical Center, Shanghai, China., Xia X; Department of Pharmacy, Zhongshan Hospital (Xiamen), Fudan University, Fujian, Xiamen, China., Lv Q; Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China. 18818263550@163.com. |
| Source: | European journal of clinical pharmacology [Eur J Clin Pharmacol] 2026 Feb 09; Vol. 82 (3), pp. 75. Date of Electronic Publication: 2026 Feb 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1432-1041 |
|---|---|
| DOI: | 10.1007/s00228-026-04004-y |
